Skip to main content
60°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
181.39
-2.61 (-1.42%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Charles River Laboratories Intl
< Previous
1
2
3
4
5
Next >
P/E Ratio Insights for Charles River
October 25, 2024
Via
Benzinga
This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
October 23, 2024
Via
Benzinga
This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
October 07, 2024
Via
Benzinga
This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
October 07, 2024
Via
Benzinga
Evaluating Charles River: Insights From 12 Financial Analysts
October 07, 2024
Via
Benzinga
The Analyst Verdict: Charles River In The Eyes Of 10 Experts
September 20, 2024
Via
Benzinga
Critical Insights From Charles River Analyst Ratings: What You Need To Know
August 08, 2024
Via
Benzinga
Demystifying Charles River: Insights From 4 Analyst Reviews
June 28, 2024
Via
Benzinga
The Analyst Verdict: Charles River In The Eyes Of 4 Experts
June 06, 2024
Via
Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.
Via
Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers.
Via
Benzinga
The Analyst Landscape: 7 Takes On Charles River
May 10, 2024
Via
Benzinga
Evaluating Charles River: Insights From 7 Financial Analysts
March 18, 2024
Via
Benzinga
EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway
August 08, 2024
Oragenics announced its lead candidate, ONP-002, for treating concussion, which shows no cardiotoxicity in studies. Designed for nasal delivery to the brain, ONP-002 aims to address the significant...
Via
Benzinga
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
August 08, 2024
Via
Benzinga
Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close
August 07, 2024
U.S. markets close lower on Wednesday after bounce back on Tuesday, with small caps hit hardest. Investors assess economic outlook and Fed rate cut.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast
August 07, 2024
Charles River Laboratories reported Q2 2024 revenue of $1.03 billion, a 3.2% decrease year-over-year, surpassing the $1.024 billion consensus. Adjusted EPS rose to $2.80 from $2.69. The company revised...
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Charles River
February 15, 2024
Via
Benzinga
Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024
August 07, 2024
Pharmaceutical demand hit the skids in the second quarter and isn't expected to improve this year.
Via
Investor's Business Daily
Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
July 10, 2024
Via
Benzinga
These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
June 28, 2024
Via
Benzinga
CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
The 7 Best Growth Stocks to Buy in May 2024
May 08, 2024
Find real bargains in this marketplace with these seven best growth stocks to buy today for your portfolio.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 07, 2024
Via
Benzinga
The Top 3 Healthcare Stocks to Buy in March 2024
March 07, 2024
There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today.
Via
InvestorPlace
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
March 07, 2024
vBitcoin has exploded higher over the past month setting an all-time record. That’s excellent news for Coinbase Global and COIN stock.
Via
InvestorPlace
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
March 06, 2024
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Via
Investor's Business Daily
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.
Via
InvestorPlace
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
February 14, 2024
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.